Yuji Ikeda

Summary

Affiliation: Saga University
Country: Japan

Publications

  1. ncbi Partial blood recirculation: a new trial for prolonging filter life during continuous hemodiafiltration
    Yuji Ikeda
    Department of Internal Medicine, Saga Medical School, Saga, Japan
    Ther Apher Dial 12:96-9. 2008
  2. ncbi Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells
    Noriko Ide
    Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    Hypertens Res 31:1257-67. 2008
  3. ncbi A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis
    Motoaki Miyazono
    Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Email
    Ther Apher Dial 12:333-6. 2008
  4. ncbi [A case of systemic lupus erythematosus patient who died of rupture of abdominal aortic aneurysm]
    Ai Nishimoto
    Department of Internal Medicine, Saga Medical School, Saga, Japan
    Nippon Jinzo Gakkai Shi 45:701-5. 2003
  5. ncbi Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-1alpha upregulation in endothelial cells
    Ai Nishimoto-Hazuku
    Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    J Cardiovasc Pharmacol 51:267-73. 2008
  6. ncbi Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient
    Yuji Ikeda
    Department of Internal Medicine, Saga Medicial School, Nabeshima
    Intern Med 41:722-4. 2002

Collaborators

  • Motoaki Miyazono
  • Yukio Okazaki
  • Noriko Ide
  • Ai Nishimoto-Hazuku
  • Tetsuaki Hirase
  • Koichi Node
  • Ai Nishimoto
  • Tomoya Kishi
  • Souichirou Haraguchi
  • Hiroshi Yamamoto
  • Taisei Fujisaki
  • Takanobu Sakemi

Detail Information

Publications6

  1. ncbi Partial blood recirculation: a new trial for prolonging filter life during continuous hemodiafiltration
    Yuji Ikeda
    Department of Internal Medicine, Saga Medical School, Saga, Japan
    Ther Apher Dial 12:96-9. 2008
    ..Our success in prolonging the filter life during this case therefore suggests that PBR might resolve one of the main problems related to CHDF, although more study is needed to clarify the advantages of this system...
  2. ncbi Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells
    Noriko Ide
    Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    Hypertens Res 31:1257-67. 2008
    ..These data indicate that IP-10 is involved not only in leukocyte-endothelial interaction but also in the circuit of endothelial renin-angiotensin system activation that potentially promotes atherosclerosis...
  3. ncbi A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis
    Motoaki Miyazono
    Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan Email
    Ther Apher Dial 12:333-6. 2008
    ..This suggests that LDL-A may therefore be an effective therapy for nephrotic syndrome due to collapsing FSGS...
  4. ncbi [A case of systemic lupus erythematosus patient who died of rupture of abdominal aortic aneurysm]
    Ai Nishimoto
    Department of Internal Medicine, Saga Medical School, Saga, Japan
    Nippon Jinzo Gakkai Shi 45:701-5. 2003
    ..Considerable attention should be paid to patients with SLE who are given prednisolone to detect and prevent vascular complications such as aneurysm...
  5. ncbi Simvastatin stimulates vascular endothelial growth factor production by hypoxia-inducible factor-1alpha upregulation in endothelial cells
    Ai Nishimoto-Hazuku
    Department of Cardiovascular and Renal Medicine, Saga University Faculty of Medicine, Saga, Japan
    J Cardiovasc Pharmacol 51:267-73. 2008
    ..This study examined whether simvastatin stimulates VEGF expression in endothelial cells as well as the nature of its underlying mechanism...
  6. ncbi Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient
    Yuji Ikeda
    Department of Internal Medicine, Saga Medicial School, Nabeshima
    Intern Med 41:722-4. 2002
    ..Four months later, bone marrow aspiration and a biopsy confirmed a diagnosis of AML M2, showing hypercellular bone marrow with 60% leukemic cells. He received induction chemotherapy, which led to a complete remission...